Search
Influenza B virus B/Washington/02/2019 live (attenuated) antigen
go.drugbank.com/drugs/DB15758ApprovedVaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (formaldehyde inactivated)
go.drugbank.com/drugs/DB16705ApprovedVaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (propiolactone inactivated)
go.drugbank.com/drugs/DB16723ApprovedWithdrawnVaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (formaldehyde inactivated)
go.drugbank.com/drugs/DB16725ApprovedWithdrawnVaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen
Hypoprothrombinemia
go.drugbank.com/conditions/DBCOND0022631Drugs: PhylloquinoneSynonyms: Factor II deficiency, NOS, Prothrombin deficiency, NOSIncontinence, Nighttime Urinary
go.drugbank.com/conditions/DBCOND0088838Synonyms: Enuresis NOS, Enuresis, NOSIrritative cough
go.drugbank.com/conditions/DBCOND0112744Drugs: DL-Methylephedrine · Dextromethorphan · Diphenhydramine · Guaifenesin · Phenylephrine · Pholcodine +1 moreSynonyms: Cough, NOS, Cough symptom NOSStage III Hodgkin's Disease
go.drugbank.com/conditions/DBCOND0111730Drugs: ProcarbazineSynonyms: Hodgkin's disease NOS stage III, Hodgkin's disease, NOS of lymph nodes of multiple sitesBlonanserin
go.drugbank.com/drugs/DB09223InvestigationalBlonanserin is an atypical antipsychotic approved in Japan in January, 2008. It offers improved tolerability as it lacks side effects such as extrapyramidal symptoms, excessive sedation, or hypotension. As a second-generation (atypical) ...